Endothelin receptor antagonists: Effect of serum albumin on potency and comparison of pharmacological characteristics

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 2, 1997, Pages 791-798

  Wu Wong, Jinshyun R ^a   Dixon, Douglas B ^a   Chiou, William J ^a   Opgenorth, Terry J ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (N,N DIBUTYLACETAMIDO) 4 (1,3 BENZODIOXOL 5 YL) 2 (4 METHOXYPHENYL)PYRROLIDINE 3 CARBOXYLIC ACID; 2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; 4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 3 (3,4,5 TRIMETHOXYBENZYL) 2 BUTENOIC ACID; ARACHIDONIC ACID; ATRASENTAN; BOSENTAN; BOVINE SERUM ALBUMIN; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; INOSITOL PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; BINDING KINETICS; DRUG POTENCY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; NONHUMAN; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL;

ACETAMIDES; ANIMALS; AZEPINES; BINDING, COMPETITIVE; CELLS, CULTURED; CHO CELLS; CRICETINAE; DIOXOLES; ENDOTHELIN-1; HYDROLYSIS; INDOLES; PHOSPHATIDYLINOSITOLS; PYRROLIDINES; RATS; RECEPTORS, ENDOTHELIN; SERUM ALBUMIN, BOVINE; SULFONAMIDES; SWINE;

EID: 0030980244     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. ARAI, H., HORI, S., ARIMORI, I., OHKUBO, H. AND NAKANISHI, S.: Cloning and expression of a cDNA encoding an endothelin receptor. Nature (Lond.) 348: 730-732, 1990.
2. ARUNLAKSHANA, O. AND SCHILD, H.: Some quantitative uses of drug antagonist. Br. J. Pharmacol. 14: 48-58, 1956.
3. BERRIDGE, M. J., DOWNES, C. P. AND HANLEY, M. R.: Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem. J. 206: 587-595, 1982.
4. BREU, V., HASHIDO, K., BROGER, C., MIYAMOTO, C., FURUICHI, Y., HAYES, A., KALINA, B., LÖFFLER, B-M, RAMUZ, H. AND CLOZEL, M.: Separable binding sites for the natural agonist endothelin-1 and the non-peptide antagonist bosentan on human endothelin-A receptor. Eur. J. Biochem. 231: 266-270, 1995.
5. CLOZEL, M., BREU, V., GRAY, G. A., KALINA, B., LÖFFLER, B.-M., BURRI, K., CASSAL, J.-M., HIRTH, G., MÜLLER, M., NEIDHART, W. AND RAMUZ, H.: Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther. 270: 228-235, 1994.
6. INOUE, A., YANAGISAWA, M., KIMURA, S., KASUYA, Y., MIYAUCHI, T., GOTO, K. AND MASAKI, T.: The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl. Acad. Sci. U.S.A. 86: 2863-2867, 1989.
7. JUDD, A. M., LOGIN, I. S., KOVACS, K., ROSS, P. C., SPANGELO, B. L., JARVIS, W. D. AND MACLEOD, R. M.: Characterization of the MMQ cell, a prolactin-secreting clonal cell line that is responsive to dopamine. Endocrinology 123: 2341-2350, 1988.
8. KOZUKA, M., ITO, T., HIROSE, S., LODHI, K. M. AND HAGIWARA, H.: Purification and characterization of bovine lung endothelin receptor. J. Biol. Chem. 266: 16892-16896, 1991.
9. MAGNUSON, S. R., CHIOU, W., SUNDY, S. A., OPGENORTH, T. J. AND WU-WONG, J. R. Cells stably expressing human type-B endothelin receptor exhibit variation in G-protein linked phosphatidyl inositol hydrolysis (Abstract). FASEB J. 8: 3569, 1994.
10. OPGENORTH, T. J.: Endothelin receptor antagonism. Adv. Pharmacol. 33: 1-65, 1995.
11. A-selective receptor antagonist. J. Pharmacol. Exp. Ther. 276: 473-481, 1996.
12. A receptor antagonist. J. Pharmacol. Exp. Ther. 273: 1410-1417, 1995.
13. SAKURAI, T., YANAGISAWA, M., TAKUWA, Y., MIYAZAKI, H., KIMURA, S., GOTO, K. AND MASAKI, T.: Cloning of a cDNA encoding a non-isopeptide selective subtype of the endothelin receptor. Nature (Lond.) 348: 732-735, 1990.
14. A receptor antagonist. J. Pharmacol. Exp. Ther. 264: 1040-1046, 1993.
15. SOKOLOVSKY, M.: Structure-function relationships of endothelins, sarafotoxins, and their receptor subtypes. J. Neurochem. 59: 809-821, 1992.
16. WADA, K., TABUCHI, H., OHBA, R., SATOH, M., TACHIBANA, Y., AKIYAMA, N., HIRAOKA, O., ASAKURA, A., MIYAMOTO, C. AND FURUICHI, Y.: Purification of an endothelin receptor from human placenta. Biochem. Biophys. Res. Commun. 167: 251-257, 1990.
17. WALSH, T. F.: Progress in the development of endothelin receptor antagonists. Annual Reports in Medicinal Chemistry, pp. 91-100, Academic Press, 1995.
18. A receptor antagonist. J. Pharmacol. Exp. Ther. 272: 1124-1134, 1995.
19. WILLIAMS, D. L. JR., MURPHY, K. L., NOLAN, N. A., O'BRIEN, J. A., PETTIBONE, D. J., KIVLIGHN, S. D., KRAUSE, S. M., LIS, E. V., ZINGARO, G. J., GABEL, R. A., CLAYTON, F. C., SIEGL, P. K. S., ZHANG, K., NAUE, J., VYAS, K., WALSH, T. F., FITCH, K. J., CHAKRAVARTY, P. K., GREENLEE, W. J. AND CLINESCHMIDT, B. V.: Pharmacology of L-754,142, a highly potent, orally active nonpeptidyl endothelin antagonist. J. Pharmacol. Exp. Ther. 275: 1518-1526, 1995.
20. WU-WONG, J. R., CHIOU, W., HOFFMAN, D. J., WINN, M., VON GELDERN, T. W. AND OPGENORTH, T. J.: Endothelins and endothelin receptor antagonists: Binding to plasma proteins. Life Sciences 58: 1839-1847, 1996.
21. WU-WONG, J. R., CHIOU, W. J., HUANG, Z.-J., VIDAL, M. J. AND OPGENORTH, T. J.: Endothelin receptor in human smooth muscle cells: Antagonist potency differs on agonist-evoked responses. Am. J. Physiol. 267: C1185-C1195, 1994a.
22. WU-WONG, J. R., CHIOU, W., NAUGLES, K. E. JR. AND OPGENORTH, T. J.: Endothelin receptor antagonists exhibit diminishing potency following incubation with agonist. Life Sciences 54: 1727-1734, 1994b.
23. WU-WONG, J. R., CHIOU, W., MAGNUSON, S. R. AND OPGENORTH, T. J.: Endothelin receptor agonists and antagonists exhibit different dissociation characteristics. Biochim. Biophys. Acta 1224: 288-294, 1994c.
24. WU-WONG, J. R., CHIOU, W., MAGNUSON, S. R., WITTE, D. G. AND LIN, C. W.: Identification and characterization of type A endothelin receptors in MMQ cells. Mol. Pharmacol. 44: 285-291, 1993.
25. YANAGISAWA, M., KURIHARA, H., KIMURA, S., TOMOBE, Y., KOBAYASHI, Y., MITSUI, M., YAZAKI, Y., GOTO, K. AND MASAKI, T.: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (Lond.) 332: 411-415, 1988.